Home » Topics » Regulatory » Patents

Patents
RSS

Korean researchers synthesize PDE5A and HDAC6 dual inhibitors for Alzheimer's

Feb. 9, 2022

Nanjing Zhengxiang Pharmaceuticals divulges DHODH inhibitors

Feb. 9, 2022

IFM Due patents hSTING antagonists for cancer

Feb. 9, 2022

Wuhan LL Science and Technology Development presents new ROCK inhibitors

Feb. 8, 2022

Chiesi Farmaceutici identifies new TGFBR1 inhibitors for IPF

Feb. 8, 2022

Beijing Tide Pharmaceutical synthesizes new ATR kinase inhibitors

Feb. 8, 2022

Researchers divulge SSTR4 agonists for treatment of pain

Feb. 8, 2022

Roche patents new TLR antagonists for autoimmune disease

Feb. 8, 2022

Bristol Myers Squibb presents new FPR agonists

Feb. 7, 2022

Klotho Therapeutics synthesizes novel compounds for hypertension

Feb. 7, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...